What you have to be very careful of is slippery terminology like “rare”. We also have to be wary of even this unmeasurable term being superseded so that now the health influencers sometimes just talk of the benefit outweighing the risk: but net benefit (which also cannot be measured) is not a sensible criterion for the en masse preventio…
What you have to be very careful of is slippery terminology like “rare”. We also have to be wary of even this unmeasurable term being superseded so that now the health influencers sometimes just talk of the benefit outweighing the risk: but net benefit (which also cannot be measured) is not a sensible criterion for the en masse prevention of a disease you haven’t got (as opposed to a risky treatment for a deadly disease you have). It may be interesting to note that the GSK Men B vaccine (Bexsero) has a lot of measurable bad side effects including 1 in 1000 cases of Kawasaki disease per shot and the child version of the AZ Covid shot was to be trialed against Bexsero. The trial seems to have been abandoned shortly after I pointed out that Bexsero may have already led to as many as 7,000 additional cases of Kawasaki in the UK.
What you have to be very careful of is slippery terminology like “rare”. We also have to be wary of even this unmeasurable term being superseded so that now the health influencers sometimes just talk of the benefit outweighing the risk: but net benefit (which also cannot be measured) is not a sensible criterion for the en masse prevention of a disease you haven’t got (as opposed to a risky treatment for a deadly disease you have). It may be interesting to note that the GSK Men B vaccine (Bexsero) has a lot of measurable bad side effects including 1 in 1000 cases of Kawasaki disease per shot and the child version of the AZ Covid shot was to be trialed against Bexsero. The trial seems to have been abandoned shortly after I pointed out that Bexsero may have already led to as many as 7,000 additional cases of Kawasaki in the UK.
https://www.bmj.com/content/372/bmj.n385/rr-1